Merck Executives to Participate in J.P. Morgan Healthcare Conference 2026
TL/DR –
Merck’s CEO, Robert M. Davis, and Dr. Dean Y. Li, president of Merck Research Laboratories, are set to participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026. The chat will be available to the public via a live audio webcast. Merck, a leading-edge science company, has been developing medicines and vaccines for over 130 years with the goal of saving and improving lives around the world.
Merck Leaders to Participate in J.P. Morgan Healthcare Conference
Merck (NYSE: MRK), also known as MSD outside the US and Canada, today announced that Robert M. Davis, CEO, and Dr. Dean Y. Li, President of Merck Research Laboratories, are set to participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026. The chat will take place at 4:30 p.m. PST / 7:30 p.m. EST.
Interested investors, analysts, media members and the public can access a live audio webcast of the presentation.
About Merck
Merck, known as MSD outside of the US and Canada, leverages leading-edge science to save and improve lives globally. For over 130 years, Merck has developed important medicines and vaccines, bringing hope to humanity. As a research-intensive biopharmaceutical company, we are at the forefront of research delivering innovative health solutions for the prevention and treatment of diseases. Learn more at www.merck.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Forward-Looking Statement
This news release of Merck & Co., Inc., Rahway, N.J., USA includes “forward-looking statements” as defined by the U.S. Private Securities Litigation Reform Act of 1995. These statements are subject to significant risks and uncertainties, and actual results may differ materially if assumptions prove inaccurate or risks materialize. Risks and uncertainties include, but are not limited to general industry and economic conditions, pharmaceutical industry regulation and health care legislation, technological advances, new products and patents by competitors, and the company’s ability to predict future market conditions. For more details, refer to the company’s Annual Report on Form 10-K for the year ended December 31, 2024 and other filings with the Securities and Exchange Commission (SEC) available at www.sec.gov.
—
Read More Health & Wellness News ; US News